RE: Blautix data24 May 2021 08:46
Just look at this bit:-
Hope the PR at 4D highlight this to the Yanks today
A particularly strong, statistically significant overall response rate was observed in female IBS-D subjects across all regions (Blautix 34.6% vs placebo 19.0%, p=0.05). This effect was enhanced and highly significant in US female IBS-D subjects (Blautix 37.9% vs placebo 9.4%, p=0.01).